GHB (gamma-hydroxybutyrate) is classified as a central nervous system (CNS) depressant. It was originally developed as an anesthetic and later used in treatment for certain medical conditions, including narcolepsy. However, due to its potential for abuse and its association with recreational use and drug-facilitated sexual assault, GHB is regulated in many countries. In the United States, for example, it is classified as a Schedule I controlled